CN201147507Y - Long-acting blood pressure-reducing sustained-release degradation stick - Google Patents

Long-acting blood pressure-reducing sustained-release degradation stick Download PDF

Info

Publication number
CN201147507Y
CN201147507Y CNU200720092419XU CN200720092419U CN201147507Y CN 201147507 Y CN201147507 Y CN 201147507Y CN U200720092419X U CNU200720092419X U CN U200720092419XU CN 200720092419 U CN200720092419 U CN 200720092419U CN 201147507 Y CN201147507 Y CN 201147507Y
Authority
CN
China
Prior art keywords
blood pressure
long
degradability
pressure reducing
polycaprolactone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNU200720092419XU
Other languages
Chinese (zh)
Inventor
郭素林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNU200720092419XU priority Critical patent/CN201147507Y/en
Application granted granted Critical
Publication of CN201147507Y publication Critical patent/CN201147507Y/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The utility model discloses a long-acting blood pressure reducing slowly-release degradation stick, which is characterized in that the long-acting blood pressure reducing slowly-release degradation stick comprises a small section of medical poly-caprolactone hose with degradability. The medical poly-caprolactone hose with degradability is filled with quantitative hypotensor and both ends of the poly-caprolactone hose are sealed by hot melt. The long-acting blood pressure reducing slowly-release degradation stick has simple structure, convenient manufacture and use, lasting effect and economy. The effect can last two years when the long-acting blood pressure reducing slowly-release degradation stick is embedded once. The medicine can be released slowly via the poly-caprolactone hose which is slightly hollow, the effective blood concentration can be guaranteed, the goal of steady reducing pressure is achieved, and the hose wall can be degraded within 2 to 3 years. The long-acting blood pressure reducing slowly-release degradation stick is suitable for various high blood pressures, reduces the trouble of a patient for long time of medicine taking and the phenomenon of a little high, a little low blood pressure resulting from forgetting to taking the medicine and taking the medicine at interval, and effectively prevents the diseases such as blood vessel of brain, etc. from happening.

Description

Long acting blood pressure reducing slow release degraded rod
Technical field:
This utility model belongs to treatment hypertension disease medicament technical field, relates to a kind of long acting blood pressure reducing slow release degraded rod.
Background technology:
The hypertension incidence rate is very high clinically, belongs to multiple chronic disease.Easily cause apoplexy, coronary heart disease, renal failure etc., at present aspect treatment, all need to obey depressor fugitive every day 3 times, long lasting every day 1 time everyday.A kind of long acting blood pressure reducing heeling-in rod that adopts silica gel tube of existing patent applied for.Though its treatment time is long, after the medicine such as grade has discharged, need to take out silica gel tube, increased misery and psychological burden to the patient.Therefore, reduce misery in order to make the patient, make blood pressure long-term steadily normal, developing long, effective, the economical and practical novel antihypertensive drugs of curative effect is present the world of medicine big problem anxious to be solved.
Summary of the invention:
The purpose of this utility model provides long, effective, the economical and practical long acting blood pressure reducing slow release degraded rod of a kind of curative effect, to remedy the deficiencies in the prior art.
For achieving the above object, the technical solution of the utility model is: it comprises a bit of medical polycaprolactone sebific duct with degradability, said medical interior filling of polycaprolactone sebific duct with degradability, the Altace Ramipril that curative effect is long, effective, therapeutic dose is low, the hot melt sealing is adopted at polycaprolactone sebific duct two ends.
Said medical interior filling of polycaprolactone sebific duct with degradability, the hypotensor that curative effect is long, effective, therapeutic dose is low is a clonidine hydrochloride.
Said medical interior filling of polycaprolactone sebific duct with degradability, the hypotensor that curative effect is long, effective, therapeutic dose is low is an indapamide.
Said medical interior filling of polycaprolactone sebific duct with degradability, the hypotensor that curative effect is long, effective, therapeutic dose is low is the hydrochloric acid moxonidine.
Said medical interior filling of polycaprolactone sebific duct with degradability, the hypotensor that curative effect is long, effective, therapeutic dose is low is a nifedipine.
In the said medical polycaprolactone sebific duct with degradability, long for 46mm, external diameter be that 2.4-2.5mm, internal diameter are 1.6-2.1mm.
The utility model discloses a kind of long acting blood pressure reducing slow release degraded rod, it is characterized in that it comprises a bit of medical polycaprolactone sebific duct with degradability, said medical interior filling of polycaprolactone sebific duct with degradability, the Altace Ramipril that curative effect is long, effective, therapeutic dose is low, the hot melt sealing is adopted at polycaprolactone sebific duct two ends.This utility model can be used for various types of hypertension, in patient's upper arm inboard, or the loose position of femoribus internus subcutaneous tissue, adopts little otch to add puncture guide bushings pin, the guiding heeling-in wherein, but the basic utility model slow release degraded of heeling-in 2-6 rod once.This utility model simple structure, making is easy to use, curative effect is lasting, economical and practical, sustainable 2 years of heeling-in curative effect, medicine can slowly discharge by polycaprolactone sebific duct microvoid, guarantee effective blood drug concentration, reach the purpose of steady blood pressure lowering, tube wall is degraded in 2-3 and is finished. and this utility model is applicable to all types of hypertension, reduces the trouble that the patient takes medicine for a long time and forgets to obey every clothes and cause blood pressure phenomenon fluctuated, effectively the generation of disease such as prevention of brain blood vessel.
Description of drawings:
Accompanying drawing is this utility model structural representation
1, is polycaprolactone sebific duct tube wall; 2, be Altace Ramipril; 3, sebific duct sealing by fusing two ends.
The specific embodiment:
Implement 1, this utility model long acting blood pressure reducing slow release degraded rod with reference to the accompanying drawings, it comprises that a bit of length is that 46mm, external diameter are that 2.4-2.5mm, internal diameter are the medical polycaprolactone sebific duct with degradability of 1.6-2.1mm, said medical interior filling of polycaprolactone sebific duct with degradability, the Altace Ramipril 2 that curative effect is long, effective, therapeutic dose is low, said medical polycaprolactone sebific duct 1 interior filling the with degradability, the Altace Ramipril 2 that curative effect is long, effective, therapeutic dose is low is clonidine hydrochlorides.The 3 two ends hot melt sealing of polycaprolactone sebific duct.
Implement 2, fill in the 1 said polycaprolactone sebific duct with degradability according to implementing, the Altace Ramipril 2 that curative effect is long, effective, therapeutic dose is low is indapamides.
Implement 3, fill in the 1 said polycaprolactone sebific duct with degradability according to implementing, the Altace Ramipril 2 that curative effect is long, effective, therapeutic dose is low is hydrochloric acid moxonidines.
Implement 4, fill in the 1 said polycaprolactone sebific duct with degradability according to implementing, the Altace Ramipril 2 that curative effect is long, effective, therapeutic dose is low is nifedipines.

Claims (6)

1, a kind of long acting blood pressure reducing slow release degraded rod, it is characterized in that it comprises a bit of medical polycaprolactone sebific duct with degradability, the said medical quantitative Altace Ramipril of the interior filling of polycaprolactone sebific duct with degradability, the hot melt sealing is adopted at polycaprolactone sebific duct two ends.
2, according to right 1 described Altace Ramipril subdermal implantation slow release degraded glue rod, the said medical quantitative hypotensor of the interior filling of polycaprolactone sebific duct with degradability of its feature is: clonidine hydrochloride 18-85mg.
3, according to right 1 described long acting blood pressure reducing slow release degraded rod, the said medical quantitative hypotensor of the interior filling of polycaprolactone sebific duct with degradability of its feature is: indapamide 18-85mg.
4, according to right 1 described long acting blood pressure reducing slow release degraded rod, the said medical quantitative hypotensor of the interior filling of polycaprolactone sebific duct with degradability of its feature is hydrochloric acid moxonidine 18-85mg.
5, according to right 1 described long acting blood pressure reducing slow release degraded rod, the said medical quantitative hypotensor of the interior filling of polycaprolactone sebific duct with degradability of its feature is nifedipine 18-85mg.
6, according to right 1 described long acting blood pressure reducing slow release degraded rod, it is characterized in that a bit of medical polycaprolactone sebific duct with degradability, long is that 46mm, external diameter are that 2.4-2.5mm, internal diameter are 1.6-2.1mm.
CNU200720092419XU 2007-10-29 2007-10-29 Long-acting blood pressure-reducing sustained-release degradation stick Expired - Fee Related CN201147507Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNU200720092419XU CN201147507Y (en) 2007-10-29 2007-10-29 Long-acting blood pressure-reducing sustained-release degradation stick

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNU200720092419XU CN201147507Y (en) 2007-10-29 2007-10-29 Long-acting blood pressure-reducing sustained-release degradation stick

Publications (1)

Publication Number Publication Date
CN201147507Y true CN201147507Y (en) 2008-11-12

Family

ID=40115277

Family Applications (1)

Application Number Title Priority Date Filing Date
CNU200720092419XU Expired - Fee Related CN201147507Y (en) 2007-10-29 2007-10-29 Long-acting blood pressure-reducing sustained-release degradation stick

Country Status (1)

Country Link
CN (1) CN201147507Y (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107970522A (en) * 2017-11-24 2018-05-01 黑龙江工程学院 A kind of degradable metal base subcutaneously carries embedding thing of medicine and preparation method thereof
CN108498508A (en) * 2018-03-23 2018-09-07 朱军星 A kind of subdermal implantation line for long-acting decompression
CN108743955A (en) * 2018-06-26 2018-11-06 吕鹏威 One kind being used for essential hypertension elastomer subdermal implantation stick

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107970522A (en) * 2017-11-24 2018-05-01 黑龙江工程学院 A kind of degradable metal base subcutaneously carries embedding thing of medicine and preparation method thereof
CN108498508A (en) * 2018-03-23 2018-09-07 朱军星 A kind of subdermal implantation line for long-acting decompression
CN108743955A (en) * 2018-06-26 2018-11-06 吕鹏威 One kind being used for essential hypertension elastomer subdermal implantation stick

Similar Documents

Publication Publication Date Title
CN201147507Y (en) Long-acting blood pressure-reducing sustained-release degradation stick
CN106943134A (en) A kind of wearable blood pressure regulation device
CN108671383A (en) The real-time diagnosis and treatment integral system of hypertension of wearable controlled drug release
CN205307590U (en) Vagina ware of dosing for medical care
CN211535697U (en) Cerebrovascular patient uses medicine feed device
CN204379521U (en) A kind of stuffy nose relieving device for health care
CN2712349Y (en) Subcutaneous implantable sustained-release silica gel rod for antipsychotics
CN207886312U (en) A kind of implant for anal fistula filling
CN110025423A (en) A kind of intestinal loop formula ostomy bracket and the ostomy bag with the intestinal loop formula ostomy bracket
CN104739536B (en) A kind of arteria coronaria blocks and fills device and the method making myocardial infarction animal model again
CN212416645U (en) Nose medicine feeding nursing device for otolaryngological patients
CN104147606A (en) Biodegradable subcutaneous implant rod used for long-acting pressure reduction
CN202409548U (en) Subcutaneous implantable antipsychotics slow-release bar device
CN202185055U (en) Long-acting subcutaneous injection bar with hypotensive medicine
CN201150664Y (en) Subcutaneous implantable sustained-release rubber stick for mental disease
CN210144777U (en) Liquid injector for hydraulic lifting of maxillary sinus
CN106821585A (en) Novel contraceptive medical instrument
CN200948194Y (en) Cylinder casing bursa type ostomy fistula
CN2870885Y (en) Long-effective depressor submerged rod
CN208426489U (en) A kind of micro sustained release connector
CN202069708U (en) Artificial tooth implant
CN205948114U (en) Gum fistula washes needle
CN205084031U (en) Psychiatric department medicine feed ware
CN201223606Y (en) Novel syringe needle head
CN101972238A (en) Prescription of phenazopyridine hydrochloride capsule and preparation process

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CU03 Correction of utility model patent gazette

Correction item: Patentee|Address

Correct: 456250 No. 68, science and technology road, Xunxian County Town, Hebi, Henan

False: 456250 No. 86, science and technology road, Xunxian County Town, Hebi, Henan

Number: 46

Page: 201

Volume: 24

ERR Gazette correction

Free format text: CORRECT: PATENTEE ^ ADDRESS; FROM: 456250 NO. 86, KEJI ROAD, CHENG TOWN, XUN COUNTY, HEBI CITY, HENAN PROVINCE TO: 456250 NO. 68, KEJI ROAD, CHENG TOWN, XUN COUNTY, HEBI CITY, HENAN PROVINCE

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20081112

Termination date: 20111029